5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds

In this article, we discuss the 5 most undervalued healthcare stocks to buy according to hedge funds. To read the detailed analysis of the healthcare industry, go directly to the 14 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds.

5. Pfizer Inc. (NYSE:PFE)

TTM PE Ratio as of October 26: 8.17

Number of Hedge Fund Holders: 73

Pfizer Inc. (NYSE:PFE) is an American multinational pharmaceutical and biotechnology company that provides its products globally. The company was founded in 1849 and is headquartered in New York.

On October 4, Pfizer Inc. (NYSE:PFE) declared a $0.41 dividend payable by December 4 to the shareholders of record on November 10. The company has been increasing its dividend for the past 12 years and as of September 16, the company has a dividend yield of 4.93%.

In the second quarter of 2023, 73 hedge funds had a stake worth nearly $1.52 billion in Pfizer Inc. (NYSE:PFE).

Diamond Hill Capital made the following comment about Pfizer Inc. (NYSE:PFE) in its Q2 2023 investor letter:

“Our bottom contributors in Q2 included health insurance company Humana, biopharmaceutical company Pfizer Inc. (NYSE:PFE) and global entertainment company Disney. Pharmaceutical giant Pfizer has been dealing with a decline in sales due to lower COVID vaccination levels. Additionally, in 2023, management is increasing spend as the company invests in new product launches. That said, we remain positive about the long-term company fundamentals.”